RE:RE:RE:RE:RE:RE:RE:RE:RE:Insiders are NOT SellingI'll tell you what Moe,
neither of us can predict the future accurately enough, but when the dust settles, and SONA hits a higher P/E than QDEL did at it's height during the pandemic, you can owe me a top-shelf triple of your area's best Sambuca.... If QDEL wins, I'll owe you your choice of top shelf? I'm good for it, I am sure you are too.
Cheers!
Moemoney42 wrote: Aarman4 wrote: Moemoney42 wrote: dart321 wrote: Take your numbers step farther and look at the other companies in our sector listed on the nazy. An example is one that sells tests at present QDEL, their PE Ratio is 67 times the others are similar and even higher in some cases. It's all about announced sales an how fast they grow.
You also have to compare apples to apples... QDEL is an established business thats been around for decades and has many products not just one..! Thus the PE ratio (although elevated lately) is relevant to the whole business not just a covid test..
I very respectfully disagree with you on this one Moemoney42.....
I have yet to see the market give higher multiples to companies just because of how long they have been around.
In fact, if anything, the P/E multiple seems to get higher for new companies at a disproportionate rate because they are the "hot stock" of the moment. Unfortunately, that P/E multiple also tends to crash down harder once the fireworks end, but that is a different answer to a different question ;)
Cheers to all!
Yes Aarman.. but the decades of an established business is only part of the reason for the P/E value... the fact that they have an established business (with many products) now with the covid test to complement it, juices the P/E to a higher multiple. SONA has yet to prove this fact... I don't know that the dot-com era of multiples applies to startups much anymore.. could be wrong..?